During the past decade, Fuwai Hospital conducted 172 clinical trials. In the 10-year time frame, 172 clinical trials started and 27 clinical trials were completed, i.e. on average, 15.7% percent of trials that started reached the finish line to date. In the past 5 years, 65 clinical trials started and 14 clinical trials were completed. i.e. 21.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fuwai Hospital" #1 sponsor was "China National Center for Cardiovascular Diseases" with 67 trials, followed by "Chinese Academy of Medical Sciences, Fuwai Hospital" with 55 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 11 trials sponsored, "Actelion" with 8 trials sponsored and "Shanghai MicroPort Medical (Group) Co., Ltd." with 8 trials sponsored. Other sponsors include 97 different institutions and companies that sponsored additional 62 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fuwai Hospital" #1 collaborator was "Peking Union Medical College Hospital" with 8 trials as a collaborator, "Beijing Anzhen Hospital" with 7 trials as a collaborator, "Fu Wai Hospital, Beijing, China" with 7 trials as a collaborator, "Guangdong Provincial People's Hospital" with 6 trials as a collaborator and "West China Hospital" with 5 trials as a collaborator. Other collaborators include 175 different institutions and companies that were collaborators in the rest 146 trials.

According to Clinical.Site data, the most researched conditions in "Fuwai Hospital" are "Coronary Artery Disease" (47 trials), "Heart Failure" (16 trials), "Hypertension" (13 trials), "Pulmonary Arterial Hypertension" (13 trials) and "Atrial Fibrillation" (11 trials). Many other conditions were trialed in "Fuwai Hospital" in a lesser frequency.

Most popular intervention types in "Fuwai Hospital" are "Drug" (80 trials), "Device" (57 trials), "Procedure" (32 trials), "Other" (25 trials) and "Behavioral" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "No intervention" (7 trials), "Tranexamic Acid" (7 trials), "rhNRG-1" (4 trials) and "Atorvastatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Fuwai Hospital" are 248 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 80 active trials in "Fuwai Hospital". 12 are not yet recruiting, 57 are recruiting, 8 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 84 completed trials in Fuwai Hospital, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Fuwai Hospital, 5 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 31 trials, and there were also 97 trials that are defined as “Not Applicable".